
Sign up to save your podcasts
Or
In this episode, we sit down with Dr. Cesar Rodriguez of Mount Sinai Hospital in New York, NY to discuss the evolving landscape of myeloma treatment. Groundbreaking innovations are bringing new hope to patients and caregivers. Dr. Rodriguez breaks down the latest advancements in immunotherapy, including CAR T-cell therapy and bispecific antibodies. Hear how researchers and physicians are working to make myeloma into a manageable, long-term disease, while ultimately searching for a cure.
Mentioned on this episode:
Additional LLS Support Resources:
Supported by Abbvie Inc.; Genentech, A Member of the Roche Group; and Johnson & Johnson.
The post Hope in Myeloma: The Road to Long-Term Survival first appeared on The Bloodline with LLS.
4.9
4343 ratings
In this episode, we sit down with Dr. Cesar Rodriguez of Mount Sinai Hospital in New York, NY to discuss the evolving landscape of myeloma treatment. Groundbreaking innovations are bringing new hope to patients and caregivers. Dr. Rodriguez breaks down the latest advancements in immunotherapy, including CAR T-cell therapy and bispecific antibodies. Hear how researchers and physicians are working to make myeloma into a manageable, long-term disease, while ultimately searching for a cure.
Mentioned on this episode:
Additional LLS Support Resources:
Supported by Abbvie Inc.; Genentech, A Member of the Roche Group; and Johnson & Johnson.
The post Hope in Myeloma: The Road to Long-Term Survival first appeared on The Bloodline with LLS.
8,554 Listeners
15,641 Listeners
1,309 Listeners
12,552 Listeners
4,760 Listeners
111,593 Listeners
1,072 Listeners
7,035 Listeners
13 Listeners
5,454 Listeners
14,534 Listeners
8,202 Listeners
790 Listeners
40,963 Listeners
523 Listeners